Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index-Reference-Cited by-同舟云学术

Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index

Author:

de Bock L.¹,Fraussen J.¹,Villar L. M.²,Álvarez-Cermeño J. C.²,Van Wijmeersch B.¹³,van Pesch V.⁴,Stinissen P.¹,Somers V.¹

Affiliation:

1. Biomedical Research Institute and Transnationale Universiteit Limburg; Hasselt University; Diepenbeek Belgium

2. Departments of Neurology and Immunology; Ramón y Cajal Hospital; Madrid Spain

3. Multiple Sclerosis and Rehabilitation Center; Overpelt Belgium

4. Institute of Neurosciences; Neurochemistry Unit; Université Catholique de Louvain; Brussels Belgium

Funder

Transnationale Universiteit Limburg, Hasselt University and the Flanders Fund for Scientific Research

Fondation Charcot

Rotary International

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

Reference25 articles.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献